Katchar Kianoosh, Taylor Claribel P, Tummala Sanjeev, Chen Xinhua, Sheikh Javed, Kelly Ciarán P
Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Clin Gastroenterol Hepatol. 2007 Jun;5(6):707-13. doi: 10.1016/j.cgh.2007.02.025.
BACKGROUND & AIMS: Individuals who mount a significant serum immunoglobulin (Ig)G response to toxin A are protected against recurrent Clostridium difficile-associated disease (CDAD). We investigated whether humoral immune deficiencies and/or specific IgG subclass responses are associated with recurrent CDAD.
We compared the clinical characteristics and humoral immune responses of 13 patients with recurrent CDAD with 13 matched controls with a single CDAD episode. We measured the serum IgG titers to tetanus and diphtheria toxoids, as well as total and toxin A- and toxin B-specific serum IgG, IgA, and IgG subclass concentrations.
There were no differences between the single and recurrent CDAD subjects in terms of age, sex, ethnicity, or other potential confounding variables. The total duration of diarrhea in patients with recurrent CDAD was greater (median, 62 vs 17 days; P = .005). IgG titers to tetanus and diphtheria toxoids, total IgG, and IgG subclass levels were similar in both groups. The total IgA was somewhat lower in those with recurrent CDAD (204 vs 254 mg/dL; P = .05). IgA, IgG, IgG1, and IgG4 anti-toxin A and anti-toxin B levels were similar in both groups. However, IgG2 and IgG3 anti-toxin A levels were significantly lower in the recurrent group (P = .01 and .001, respectively).
Subjects with recurrent CDAD did not show evidence of widespread humoral immune deficiency or of IgG subclass deficiency. Their low serum IgG anti-toxin A concentrations reflected selectively reduced IgG2 and IgG3 subclass responses. Measurement of specific IgG2/3 anti-toxin A may be useful in selecting patients for treatment with agents to prevent recurrent CDAD.
对毒素A产生显著血清免疫球蛋白(Ig)G反应的个体可预防复发性艰难梭菌相关性疾病(CDAD)。我们调查了体液免疫缺陷和/或特异性IgG亚类反应是否与复发性CDAD相关。
我们比较了13例复发性CDAD患者与13例匹配的单次CDAD发作对照者的临床特征和体液免疫反应。我们测量了破伤风和白喉类毒素的血清IgG滴度,以及总血清和毒素A及毒素B特异性血清IgG、IgA和IgG亚类浓度。
单次和复发性CDAD受试者在年龄、性别、种族或其他潜在混杂变量方面无差异。复发性CDAD患者腹泻的总持续时间更长(中位数,62天对17天;P = 0.005)。两组破伤风和白喉类毒素的IgG滴度、总IgG和IgG亚类水平相似。复发性CDAD患者的总IgA略低(204对254mg/dL;P = 0.05)。两组的IgA、IgG、IgG1和IgG4抗毒素A和抗毒素B水平相似。然而,复发性组中IgG2和IgG3抗毒素A水平显著降低(分别为P = 0.01和0.001)。
复发性CDAD受试者未显示广泛体液免疫缺陷或IgG亚类缺陷的证据。他们血清中抗毒素A的IgG浓度较低反映了IgG2和IgG3亚类反应选择性降低。测量特异性IgG2/3抗毒素A可能有助于选择使用预防复发性CDAD药物治疗的患者。